ArticleAdvances in therapy2022

Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan.

Atsuya Miki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.